ATE503486T1 - Osteoblasten-zusammensetzung aus halbverfestigtem gemischtem fibrin zur agglutination von knochenfrakturen und herstellungsverfahren dafür - Google Patents

Osteoblasten-zusammensetzung aus halbverfestigtem gemischtem fibrin zur agglutination von knochenfrakturen und herstellungsverfahren dafür

Info

Publication number
ATE503486T1
ATE503486T1 AT05774219T AT05774219T ATE503486T1 AT E503486 T1 ATE503486 T1 AT E503486T1 AT 05774219 T AT05774219 T AT 05774219T AT 05774219 T AT05774219 T AT 05774219T AT E503486 T1 ATE503486 T1 AT E503486T1
Authority
AT
Austria
Prior art keywords
osteoblast
semi
bone
composition
fibrin
Prior art date
Application number
AT05774219T
Other languages
English (en)
Inventor
Hyun-Shin Park
Jae-Deog Jang
Cheong-Ho Chang
Soo-Jin Jung
Sae-Bom Lee
Chang-Kwon Ko
Original Assignee
Sewon Cellontech Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sewon Cellontech Co Ltd filed Critical Sewon Cellontech Co Ltd
Application granted granted Critical
Publication of ATE503486T1 publication Critical patent/ATE503486T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/32—Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A61K38/363—Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4833—Thrombin (3.4.21.5)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Hematology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Virology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Meat, Egg Or Seafood Products (AREA)
AT05774219T 2005-06-13 2005-08-03 Osteoblasten-zusammensetzung aus halbverfestigtem gemischtem fibrin zur agglutination von knochenfrakturen und herstellungsverfahren dafür ATE503486T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020050050450A KR100702250B1 (ko) 2005-06-13 2005-06-13 피브린 혼합형 골절 유합용 반고형성 뼈세포 조성물 및이의 제조방법
PCT/KR2005/002531 WO2006135126A1 (en) 2005-06-13 2005-08-03 Osteoblast composition of semi-solidified mixed fibrin for bone fracture agglutination and its manufacturing method

Publications (1)

Publication Number Publication Date
ATE503486T1 true ATE503486T1 (de) 2011-04-15

Family

ID=37532459

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05774219T ATE503486T1 (de) 2005-06-13 2005-08-03 Osteoblasten-zusammensetzung aus halbverfestigtem gemischtem fibrin zur agglutination von knochenfrakturen und herstellungsverfahren dafür

Country Status (19)

Country Link
US (1) US20080213229A1 (de)
EP (1) EP1890713B1 (de)
JP (1) JP2008532723A (de)
KR (1) KR100702250B1 (de)
CN (1) CN101247814A (de)
AT (1) ATE503486T1 (de)
BR (1) BRPI0520049B8 (de)
CY (1) CY1111795T1 (de)
DE (1) DE602005027260D1 (de)
DK (1) DK1890713T3 (de)
ES (1) ES2362430T3 (de)
HR (1) HRP20110391T1 (de)
MX (1) MX2007012041A (de)
PL (1) PL1890713T3 (de)
PT (1) PT1890713E (de)
RS (1) RS51724B (de)
SG (1) SG162750A1 (de)
SI (1) SI1890713T1 (de)
WO (1) WO2006135126A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101037002B1 (ko) * 2008-09-30 2011-05-25 세원셀론텍(주) 연골세포 조기배양을 위한 연골세포 특이적 배양방법
KR100932945B1 (ko) 2009-01-16 2009-12-21 원광대학교산학협력단 골 분말과 피브린 글루로 이루어진 고형의 스캐폴드
KR100932948B1 (ko) * 2009-01-16 2009-12-21 원광대학교산학협력단 Ｂｍｐ-2를 함유하는 골 분말과 피브린 글루로 이루어진 고형의 스캐폴드
WO2020161747A1 (en) * 2019-02-08 2020-08-13 Regrow Biosciences Private Limited Osteoblast cell-mixture, and implementations thereof
CN113827778B (zh) * 2021-11-03 2022-10-21 浙江赛灵特医药科技有限公司 一种注射式骨修复剂及其应用
CN113975468A (zh) * 2021-11-11 2022-01-28 成都中科娥皇健康咨询有限公司 一种骨膜组织老化修复剂及其制备工艺

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5972703A (en) * 1994-08-12 1999-10-26 The Regents Of The University Of Michigan Bone precursor cells: compositions and methods
US6599515B1 (en) * 1995-01-16 2003-07-29 Baxter International Inc. Fibrin porous structure
DE19949290A1 (de) * 1999-10-12 2001-04-26 Albrecht Bettermann Partikuläres Konstrukt zur Verwendung in der Transplantationsmedizin
DE19956503A1 (de) * 1999-11-24 2001-06-21 Universitaetsklinikum Freiburg Spritzbares Knochenersatzmaterial
CN1426290A (zh) * 2000-03-03 2003-06-25 史密夫和内修有限公司 用于骨缺陷的定形颗粒和组合物以及该颗粒的制作方法
IL144446A0 (en) * 2001-07-19 2002-05-23 Prochon Biotech Ltd Plasma protein matrices and methods for their preparation
KR100522457B1 (ko) * 2002-04-13 2005-10-18 주식회사 셀론텍 뼈세포의 배양방법 및 조성물
EP1635887A2 (de) * 2003-06-12 2006-03-22 Interface Biotech A/S Verfahren zur zellimplantation
US7316822B2 (en) * 2003-11-26 2008-01-08 Ethicon, Inc. Conformable tissue repair implant capable of injection delivery

Also Published As

Publication number Publication date
BRPI0520049B1 (pt) 2020-12-22
SI1890713T1 (sl) 2011-07-29
DK1890713T3 (da) 2011-06-27
EP1890713A4 (de) 2009-07-08
EP1890713B1 (de) 2011-03-30
DE602005027260D1 (de) 2011-05-12
PL1890713T3 (pl) 2011-09-30
KR20060129795A (ko) 2006-12-18
JP2008532723A (ja) 2008-08-21
WO2006135126A1 (en) 2006-12-21
ES2362430T3 (es) 2011-07-05
HRP20110391T1 (hr) 2011-06-30
MX2007012041A (es) 2008-03-10
KR100702250B1 (ko) 2007-04-03
EP1890713A1 (de) 2008-02-27
CY1111795T1 (el) 2015-10-07
BRPI0520049A2 (pt) 2009-04-14
SG162750A1 (en) 2010-07-29
US20080213229A1 (en) 2008-09-04
CN101247814A (zh) 2008-08-20
PT1890713E (pt) 2011-06-09
BRPI0520049B8 (pt) 2021-05-25
RS51724B (sr) 2011-10-31

Similar Documents

Publication Publication Date Title
Fennema et al. Ectopic bone formation by aggregated mesenchymal stem cells from bone marrow and adipose tissue: a comparative study
Shiu et al. The roles of cellular and molecular components of a hematoma at early stage of bone healing
Dhillon et al. Orthobiologics and platelet rich plasma
Wu et al. Platelet‐rich fibrin increases cell attachment, proliferation and collagen‐related protein expression of human osteoblasts
Hosseini et al. In vitro osteogenic differentiation of stem cells with different sources on composite scaffold containing natural bioceramic and polycaprolactone
Yoshida et al. Peripheral blood mononuclear cells enhance the anabolic effects of platelet‐rich plasma on anterior cruciate ligament fibroblasts
Orsi et al. A unique heterologous fibrin sealant (HFS) as a candidate biological scaffold for mesenchymal stem cells in osteoporotic rats
Kuehlfluck et al. RIA fractions contain mesenchymal stroma cells with high osteogenic potency
Ghiasi et al. The effects of synthetic and natural scaffolds on viability and proliferation of adipose-derived stem cells
CY1111795T1 (el) Συνθεση οστεοβλαστη ημιστερεοποιημενης αναμεμιγμενης φιμπρινης για συγκολληση καταγματος οστου και η μεθοδος παρασκευης αυτης
Bou Assaf et al. Evaluation of the osteogenic potential of different scaffolds embedded with human stem cells originated from Schneiderian membrane: an in vitro study
Neubauer et al. The Effect of Blood‐Derived Products on the Chondrogenic and Osteogenic Differentiation Potential of Adipose‐Derived Mesenchymal Stem Cells Originated from Three Different Locations
Montes-Medina et al. Effect of bone marrow stromal cells in combination with biomaterials in early phases of distraction osteogenesis: An experimental study in a rabbit femur model
Li et al. Use of a biological reactor and platelet-rich plasma for the construction of tissue-engineered bone to repair articular cartilage defects
Zou et al. Phenotypic, trophic, and regenerative properties of mesenchymal stem cells from different osseous tissues
Al-Qadhi et al. The gingiva from the tissue surrounding the bone to the tissue regenerating the bone: a systematic review of the osteogenic capacity of gingival mesenchymal stem cells in preclinical studies
CY1111582T1 (el) Συνθεση σχηματισμου οστου που αποτελειται απο μιγμα οστεοβλαστη και βιο-θεμελιας ουσιας και μεθοδος παρασκευης αυτης
Wang et al. Biopanning of mouse bone marrow mesenchymal stem cell affinity for cyclic peptides
Chen et al. Synergetic effects of hBMSCs and hPCs in osteogenic differentiation and their capacity in the repair of critical-sized femoral condyle defects
Park et al. FGF2/HGF priming facilitates adipose-derived stem cell-mediated bone formation in osteoporotic defects
Mobini et al. Bone tissue engineering in the maxillofacial region: The state-of-the-art practice and future prospects
Nino‐Fong et al. Scaffold effects on osteogenic differentiation of equine mesenchymal stem cells: an in vitro comparative study
Shevchenko et al. The effect of osteosubstitution by platelet-rich autofibrin and hydroxyapatite ceramic with ß-tricalcium phosphate on biochemical parameters of blood in rabbits
MY136958A (en) Semi-solid osteoblast composition containing fibrin for bone union and method preparing the same
Kamal et al. Comparison of cultured mesenchymal stem cells derived from bone marrow or peripheral blood of rats

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1890713

Country of ref document: EP